US FDA Misses Point On NAC In Supplements, Avoids Answering Questions, CRN Argues

Retroactive Decisions Against Other Ingredients Likely, Trade Group Suggests

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.